Brief: MEI Pharma Says Recommendation By MEI Board To Proceed With Pending Infinity Transaction Remains Unchanged
27/06/2023 22:40
June 27 (Reuters) - MEI Pharma Inc MEIP.O :
* RECOMMENDATION BY MEI BOARD TO PROCEED WITH PENDING
INFINITY
TRANSACTION REMAINS UNCHANGED.
Source text for Eikon: ID:nBwYMLgCa
Further company coverage: MEIP.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations